Keros Therapeutics, Inc. - COM (KROS)

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Equity / COM
Number of holders
103
Total Shares
22.8M
Shares change
+395K
Total reported value, excl. options
$727M
Value change
+$7.88M
Put/Call ratio
0.01
Number of buys
50
Number of sells
-49
Price
$31.88
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.